Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test
Not Applicable
Completed
- Conditions
- Anal Canal HPV Infection DiagnosisAnal Dysplasia DiagnosisAnal Cancer
- Interventions
- Device: HC2 collection kit with a swab or brush
- Registration Number
- NCT01104181
- Lead Sponsor
- Laser Surgery Care
- Brief Summary
This is a study to determine if HC2 HPV testing in the anal canal can detect high-risk HPV and whether this aids in identifying individuals are risk for anal cancer or precancerous lesions.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
- male or female 18 years of age or older
- screened for anal dysplasia, including MSM and women -
Exclusion Criteria
- subject has had a previous treatment for anal cancer.
- subjects that have used enemas or other foreign substances, in the anal canal or anal sex within 24 hours of collection.
- subjects that have bleeding disorders or use anticoagulation treatments. -
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description swab and brush or swab and swab HC2 collection kit with a swab or brush we will determine which collection method is superior
- Primary Outcome Measures
Name Time Method HC2 can accurately test for oncogenic HPV in anal specimens in approximately 12 months Determination that HC2 testing in the anal canal can be performed
- Secondary Outcome Measures
Name Time Method Sensitivity and specificity of cytology with HC2 in approximately 12 months To determine if HC2 improves the sensitivity and specificity of anal cytology
Trial Locations
- Locations (1)
Laser Surgery Care, Inc.
🇺🇸New York, New York, United States